Pharmaceutical Strategies in the Treatment of Respiratory Diseases
American Journal of Pharmaceutics · 30.06.2025 · 6 (3) · 25-34
DOI: 10.71465/ajph2742 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Pharmaceutics, online erschienen am 30.06.2025. Verfasst von Dr. Ahmed Khan. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis, represent a significant burden on global health. Pharmaceutical strategies have played a critical role in the management and treatment of these diseases. This article provides an in-depth review of current pharmaceutical treatments, including bronchodilators, corticosteroids, biologic therapies, and newer investigational drugs. We also discuss challenges in drug delivery and the future of personalized medicine in the management of respiratory diseases.
Zitieren
APA
Khan, D. A. (2025). Pharmaceutical Strategies in the Treatment of Respiratory Diseases. American Journal of Pharmaceutics, 6(3), 25-34. https://doi.org/10.71465/ajph2742
Vancouver
Khan DA. Pharmaceutical Strategies in the Treatment of Respiratory Diseases. American Journal of Pharmaceutics. 2025;6(3):25-34. doi:10.71465/ajph2742
BibTeX
@article{Khan2025,
author = {Khan, Dr. Ahmed},
title = {Pharmaceutical Strategies in the Treatment of Respiratory Diseases},
journal = {American Journal of Pharmaceutics},
year = {2025},
volume = {6},
number = {3},
pages = {25--34},
doi = {10.71465/ajph2742}
}
EUVIMED